1
|
Detection of persistent vegetative bacteria and amplified viral nucleic acid from in-use testing of gastrointestinal endoscopes.
|
J Hosp Infect
|
1998
|
1.28
|
2
|
Preliminary evidence for biologic activity of toceranib phosphate (Palladia(®)) in solid tumours.
|
Vet Comp Oncol
|
2011
|
1.15
|
3
|
Is biofilm accumulation on endoscope tubing a contributor to the failure of cleaning and decontamination?
|
J Hosp Infect
|
2004
|
1.15
|
4
|
Seroprevalence of markers for hepatitis B, C and G in male and female prisoners--NSW, 1996.
|
Aust N Z J Public Health
|
1999
|
0.95
|
5
|
Duck hepatitis B virus: a model to assess efficacy of disinfectants against hepadnavirus infectivity.
|
Epidemiol Infect
|
1991
|
0.91
|
6
|
The current pattern of hepatitis B virus infection in Australia.
|
J Viral Hepat
|
2006
|
0.88
|
7
|
Biofilm removal by medical device cleaners: comparison of two bioreactor detection assays.
|
J Hosp Infect
|
2010
|
0.84
|
8
|
Evaluation of image quality using 1 : 1 pitch and 1.5 : 1 pitch helical CT in children: a comparative study.
|
Pediatr Radiol
|
1996
|
0.82
|
9
|
2',3'-dideoxy-3'-fluoroguanosine inhibits duck hepatitis B virus in vivo.
|
J Viral Hepat
|
1996
|
0.81
|
10
|
Evaluation of disinfection and sterilization of reusable angioscopes with the duck hepatitis B model.
|
J Vasc Surg
|
1999
|
0.79
|
11
|
The role of biofilm formation in percutaneous Kirschner-wire fixation of radial fractures.
|
J Hand Surg Br
|
2002
|
0.76
|
12
|
Establishment of an in-use testing method for evaluating disinfection of surgical instruments using the duck hepatitis B model.
|
J Hosp Infect
|
1996
|
0.76
|
13
|
Delipidation of a hepadnavirus: Viral inactivation and vaccine development.
|
J Virol Methods
|
2006
|
0.76
|
14
|
Abuse of the National Health Service.
|
Br Med J
|
1979
|
0.75
|
15
|
Vencor files for bankruptcy, employees will be paid.
|
Provider
|
1999
|
0.75
|
16
|
The truth about cats and dogs. Weighing the pros and cons of pet therapy.
|
Provider
|
1998
|
0.75
|
17
|
JCAHO issues assisted living accreditation principles.
|
Provider
|
1999
|
0.75
|
18
|
Court gives a qualified nod to community placements.
|
Provider
|
1999
|
0.75
|
19
|
Jostling for elbow room. As competition intensifies, assisted living companies broaden their services and look for new markets.
|
Provider
|
1999
|
0.75
|
20
|
Long-term care on auction block. The key question is, who will own the companies?
|
Provider
|
2000
|
0.75
|
21
|
Bankrupt chains regrouping as climate improves.
|
Provider
|
2001
|
0.75
|
22
|
The hectic life of an MDS (minimum data set) coordinator.
|
Provider
|
2001
|
0.75
|
23
|
The preparation, characterisation, and DNA adduct profile of 2-amino-2-methyl-3-butanoneoximedichloroplatinum(II), a platinum(II) complex designed to bind to GpA sequences of DNA.
|
J Inorg Biochem
|
2000
|
0.75
|
24
|
Sun gains more time.
|
Provider
|
2001
|
0.75
|
25
|
New Mexico to set new staffing levels for nursing facilities.
|
Provider
|
2000
|
0.75
|
26
|
HCFA plans a quality check in financially troubled facilities.
|
Provider
|
1999
|
0.75
|
27
|
Coxsackie group A in oysters and mussels.
|
Lancet
|
1973
|
0.75
|
28
|
Fitting into a new role. Retrofitting a nursing facility to an assisted living residence is no easy task.
|
Provider
|
1998
|
0.75
|
29
|
East and west of Eden. Caregivers choose from single-pet visits to Edenization.
|
Provider
|
1998
|
0.75
|
30
|
Rebuilding through bankruptcy.
|
Provider
|
2000
|
0.75
|
31
|
Mezzanine financing bridges mortgage gap.
|
Provider
|
1998
|
0.75
|
32
|
Life at College Park. The challenges and triumphs of the people who live and work in ICFs/MR.
|
Provider
|
1999
|
0.75
|
33
|
Quest for smaller, homelike settings spurs suits. ADA used in court cases seeking alternatives to ICFs/MR.
|
Provider
|
1999
|
0.75
|
34
|
Identification of T-cell epitopes associated with immunity within the surface protein of duck hepatitis B virus.
|
J Viral Hepat
|
2006
|
0.75
|
35
|
Synthetic leases offer genuine benefits.
|
Provider
|
1998
|
0.75
|
36
|
Bill would expedite residents' return from hospital.
|
Provider
|
1999
|
0.75
|
37
|
Community physician: a statutory consultant.
|
Br Med J
|
1973
|
0.75
|
38
|
Top nursing facility chains.
|
Provider
|
2000
|
0.75
|
39
|
Genesis Health Ventures restructures multicare acquisition.
|
Provider
|
2000
|
0.75
|
40
|
Baltimore facilities battle over 'whites only' bequest.
|
Provider
|
2000
|
0.75
|
41
|
Seniors housing still booming, not overbuilt, study says.
|
Provider
|
1999
|
0.75
|
42
|
Corruption in Oklahoma. FBI probe uncovers criminal activity in nursing facility inspection process.
|
Provider
|
2000
|
0.75
|
43
|
Postexposure treatment of experimental DHBV infection: a new therapeutic strategy.
|
J Med Virol
|
1990
|
0.75
|
44
|
Bankruptcy update: a new name for Vencor, continued progress.
|
Provider
|
2001
|
0.75
|
45
|
A market of contrasts. While stocks dry up, new financing options emerge for assisted living companies.
|
Provider
|
1998
|
0.75
|
46
|
Surviving PPS.
|
Provider
|
2000
|
0.75
|
47
|
Seniors housing especially popular with low-income seniors.
|
Provider
|
1999
|
0.75
|
48
|
Going with the flow. Providers expand service to create a smooth continuum of care.
|
Provider
|
2000
|
0.75
|
49
|
Assisted living's delicate balance. Operators face new challenges as they offer more nursing care.
|
Provider
|
1997
|
0.75
|
50
|
The Y2K fix. Planning for business as usual despite potential disruptions, ranging from water to phone to finances.
|
Provider
|
1999
|
0.75
|
51
|
California governor vetoes nursing facility reform bill.
|
Provider
|
1999
|
0.75
|
52
|
IHS' reorganization plan taking shape.
|
Provider
|
2001
|
0.75
|
53
|
Assisted living goes high tech.
|
Provider
|
1998
|
0.75
|
54
|
Solomont Bailis walks where competitors haven't thought to tread--with an eye to the future.
|
Provider
|
1999
|
0.75
|
55
|
Top 30 assisted living chains. Mergers, expansion drive shift in assisted living rankings.
|
Provider
|
1999
|
0.75
|
56
|
Sun works to build reorganization deal.
|
Provider
|
1999
|
0.75
|
57
|
Effects of Phyllanthus plant extracts on duck hepatitis B virus in vitro and in vivo.
|
Antiviral Res
|
1992
|
0.75
|
58
|
Letter: Community medicine--a disclaimer.
|
Br Med J
|
1974
|
0.75
|
59
|
Expansion strong in 1999 but will be slower next year.
|
Provider
|
1999
|
0.75
|